Preparation, Structural Characterization of Anti-Cancer Drugs-Mediated Self-Assembly from the Pluronic Copolymers through Synchrotron SAXS Investigation.

Tz-Feng Lin, Wei-Chieh Wang, Xin-Yu Zeng, Yi-Xian Lu, Pei-Jung Shih

Abstract read

In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

iRGD-TRP-PK1-modified red blood cell membrane vesicles as a new chemotherapeutic drug delivery and targeting system in head and neck cancer.Theranostics · 2025
Article
Self-Assembled Polymers for Gastrointestinal Tract Targeted Delivery through the Oral Route: An Update.Polymers · 2023
Review
Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment.Gels (Basel, Switzerland) · 2023
Article
Direct and Reverse Pluronic Micelles: Design and Characterization of Promising Drug Delivery Nanosystems.Pharmaceutics · 2022
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tz-Feng LinDepartment of Fiber and Composite Materials, Feng Chia University, Taichung 407, Taiwan.ORCID 0000-0001-8539-777X

Wei-Chieh WangDepartment of Fiber and Composite Materials, Feng Chia University, Taichung 407, Taiwan.

Xin-Yu ZengDepartment of Fiber and Composite Materials, Feng Chia University, Taichung 407, Taiwan.

Yi-Xian LuMaster's Program of Biomedical Informatics and Biomedical Engineering, Feng Chia University, Taichung 407, Taiwan.

Pei-Jung ShihDepartment of Fiber and Composite Materials, Feng Chia University, Taichung 407, Taiwan.

Funding

Ministry of Science and Technology 108-2218-E-035-015-MY2Ministry of Science and Technology 110-2221-E-035-026Ministry of Science and Technology 111-2221-E-035-006

6 · The paper itself

Abstract

Chemotherapy drugs are mainly administered via intravenous injection or oral administration in a very a high dosage. If there is a targeted drug vehicle which can be deployed on the tumor, the medical treatment is specific and precise. Binary mixing of biocompatible Pluronic

Indexed as

biomedical compositedrug carrierhydrogellamellarmicellemicroenvironmentself-assembly

Identifiers

PMID35955322

DOI10.3390/ma15155387

PMCPMC9369513

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.